Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-04

FDA Approved: ZOLPIDEM TARTRATE — Original Application (Breckenridge Pharmaceutical, Inc.)

View source ↗

Summary

FDA approves Breckenridge Pharmaceutical's original ANDA for zolpidem tartrate, a generic sleep-aid formulation for insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem Tartrate (zolpidem tartrate)

Snippet

ORIG AP for ZOLPIDEM TARTRATE (ZOLPIDEM TARTRATE)